|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-7-27
|
|
pubmed:abstractText |
Post hoc analyses evaluated the effect of infliximab upon concurrent perianal Crohn disease (CD) in a subpopulation of 31 patients from REACH, a randomized trial of 112 children with moderately to severely active luminal CD.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1536-4801
|
|
pubmed:author |
pubmed-author:BaldassanoRobert NRN,
pubmed-author:CohenStanleyS,
pubmed-author:CrandallWallaceW,
pubmed-author:FerryGeorgeG,
pubmed-author:GriffithsAnneA,
pubmed-author:HeuschkelRobertR,
pubmed-author:HyamsJeffreyJ,
pubmed-author:KugathasanSubraS,
pubmed-author:LiuGraceG,
pubmed-author:MarkowitzJamesJ,
pubmed-author:OlsonAllanA,
pubmed-author:Veereman-WautersGigiG,
pubmed-author:WinterHarlandH,
pubmed-author:ZrubekJulieJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
183-90
|
|
pubmed:meshHeading |
pubmed-meshheading:19561542-Adolescent,
pubmed-meshheading:19561542-Anal Canal,
pubmed-meshheading:19561542-Anti-Inflammatory Agents,
pubmed-meshheading:19561542-Antibodies, Monoclonal,
pubmed-meshheading:19561542-Child,
pubmed-meshheading:19561542-Crohn Disease,
pubmed-meshheading:19561542-Drug Therapy, Combination,
pubmed-meshheading:19561542-Female,
pubmed-meshheading:19561542-Humans,
pubmed-meshheading:19561542-Male,
pubmed-meshheading:19561542-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH.
|
|
pubmed:affiliation |
Nationwide Children's Hospital, Columbus, OH 43205, USA. Wallace.Crandall@NationwideChildrens.org
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
